Vironix | AI for early detection of heart and lung failure

Full Physiological Monitoring

At Vironix, we create remote patient care products that save lives and raise quality-of-life for those afflicted with Heart Failure, COPD, Asthma, and Acute Respiratory Illness.

Remote Physiological Monitoring

Chronic Care Management

AI & Automation

Our Motivation

Either you or someone you know has been impacted by heart or lung disease.

17.9 MILLION PEOPLE

die each year from cardiovascular disease.

That’s one death every 56 seconds.

People diagnosed with or at risk of heart failure, COPD, asthma, & acute respiratory illness face constant risk of death, hospitalization, massive healthcare expenditures, and persistent anxiety. If detected and managed early, singular health deterioration episodes, which include exacerbations & infections, can be readily addressed at home with diet, medications, and rest.

$400 BILLION

is the cost of preventable heart and lung disease to employers and health insurance providers

Vironix's Managed API

Vironix’s API offers disease-specific intelligence at home. Enhance your products with clinically validated machine-learning algorithms for personalized, remote diagnostics and decision support.

Offer Intelligence

Dependencies Included

Customizable & Flexible

Peer-Reviewed, World Class R&D

Clinically validated algorithms built by scientists and clinicians.

Heart Failure

Heart failure algorithms deliver highly accurate assessments (as compared to cardiologists and triage specialists) of when existing diuretic/BP therapy regimens are poorly optimized and patients should seek physician or hospital care.

COPD

Chronic Lung Disease Models Outperform Pulmonary Critical Care Specialists in Identifying Clinically Significant Health Deterioration At-Home

Asthma

Pre/Post Observational trials show that minutes of weekly decision support app engagement yields clinically significant reduction in anxiety.

Covid-19

Covid-19 algorithms exhibit strong accuracy, sensitivity, and specificity at diagnosing severe Covid-19 presentations in diverse global populations.

Influenza

Feature importance studies on influenza show minor variation in most important clinical characteristics associated with severe influenza when comparing two methods of patient training data generation.

Recent News

Vironix Health to Deploy Remote Therapeutic Monitoring Capability in The Vancouver Clinic's Transitional Care Team

2022-11-16

The Vancouver Clinic (TVC) is utilizing Vironix Health’s AI-Enabled Remote Patient Care Products to Combat Preventable Heart Disease Hospitalizations in Vancouver, WA

2022 OPTIMIZE Conference

2022-10-01

Vironix Health team members, Sumanth Swaminathan, Botros Toro, and Chris Landon participated in the 2022 OPTIMIZE Conference held Sept 21st-22nd at the historic Churchill Downs. After the team members gave their invited talk as one of 8 global innovation search finalists in the Aging2.0 competition, they presented the winning trophy in a horse race named after Vironix Health!!

Vironix Health has teamed up with Oxford University

2022-08-18

Exciting new research partnership: Vironix Health has teamed up with Oxford University to develop novel prediction methods for proactive intervention on Congestive Heart Failure.

About Vironix

Vironix was formed by passionate scientists, physicians, technologists, and entrepreneurs who have amassed decades of research, development, and commercialization expertise in the development, testing, and commercialization of medical technology.

Vironix specializes in early detection and remote care of infectious and chronic illnesses. Visit our product pages to learn more about our RPM and API offerings, and take a look at our science page to see the depth of scientific rigor and human testing that has gone into Vironix’s innovations.

Vironix remote physiological monitoring & disease-specific AI intelligence for respiratory and cardiovascular chronic illnesses